Related Experiment Video
Updated: Apr 12, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment
Ming Liu, Dunqiang Ren, Dong Wu
1Department of Pediatrics and Adolescent Medicine Li Ka Shing Faculty of Medicine, The University of Hong Kong China. wwtu@hku.hk.
Abstract:
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease resulting from multiplex causes. Evidence indicates that stem/progenitor cells might play a key role in IPF pathogenesis and repair, which may provide some novel potential strategies for the future treatment of IPF. In this review, we first summarize the current understanding of the relationship between stem cells and IPF and then review the advancements made in recent clinical trials using stem/progenitor cells, especially mesenchymal stem cells, in treating IPF and their interpretations.
Related Concept Videos
EPS and iPS Cells in Disease Research
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Regulation of Hematopoietic Stem Cells

